Back to Riskipedia Index

The FDA oversees the integrity of pharmaceutical supply chains through initiatives that help protect consumers from exposure to substandard drugs and ensure that safe and effective drugs reach U.S. consumers. However, FDA actions can present a complex set of supply chain risks and business interruptions, particularly to pharmaceutical supply chains sourcing ingredients from outside the United States. For example, FDA actions may prevent drugs from entering the US if a sub-tier ingredients supplier is in violation of FDA standards.

Back to Riskipedia Index